ERBB2 and breast cancer: In addition, existing studies have reported that ERBB2 (Lucci et al., 2010; Alcalá-Corona et al., 2018; Prat et al., 2020), STARD3 (Sahlberg et al., 2013; Vassilev et al., 2015; Alcalá-Corona et al., 2018), GRB7 (Lucci et al., 2010; Natrajan et al., 2010; Sahlberg et al., 2013; Alcalá-Corona et al., 2018; Tang et al., 2019), C17orf37 (Natrajan et al., 2010), PGAP3 (Alcalá-Corona et al., 2018), PSMD3 (Sahlberg et al., 2013), and DUSP10 (Lucci et al., 2010) played an important role in the development and progression of breast cancer.